Nuzenio

Agio

Agio news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Agios Pharmaceuticals (AGIO) In Focus On Earnings As Undervalued Narrative Holds - simplywall.stsimplywall.st · Sat, 08 Aug 2026 20:21:55 GMTAgios Pharmaceuticals, Inc. (AGIO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS NewswireACCESS Newswire · Sat, 08 Aug 2026 06:05:25 GMTAGIO Maintained by JP Morgan -- Price Target Raised to $34 - GuruFocusGuruFocus · Fri, 07 Aug 2026 16:47:42 GMTAgios Pharmaceuticals (NASDAQ:AGIO) Price Target Raised to $34.00 at JPMorgan Chase & Co. - MarketBeatMarketBeat · Fri, 07 Aug 2026 16:00:02 GMTAgios Pharmaceuticals (AGIO) Chief Medical Officer Sarah Gheuens Sells 30,000 Shares - GuruFocusGuruFocus · Fri, 07 Aug 2026 06:56:15 GMTAgios Pharmaceuticals (AGIO) CMO sells 30,000 shares in plan trade - Stock TitanStock Titan · Thu, 06 Aug 2026 20:14:18 GMTHow Surging Revenue With Ongoing Losses Will Impact Agios Pharmaceuticals (AGIO) Investors - simplywall.stsimplywall.st · Thu, 06 Aug 2026 18:31:06 GMTAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Agios Pharma (AGIO), Novavax (NVAX) and Keros Therapeutics (KROS) - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 05:38:00 GMT

Timeline

Sat, 08 Aug 2026 20:21:55 GMTAgios Pharmaceuticals (AGIO) In Focus On Earnings As Undervalued Narrative Holds - simplywall.st
Sat, 08 Aug 2026 06:05:25 GMTAgios Pharmaceuticals, Inc. (AGIO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Fri, 07 Aug 2026 16:47:42 GMTAGIO Maintained by JP Morgan -- Price Target Raised to $34 - GuruFocus
Fri, 07 Aug 2026 16:00:02 GMTAgios Pharmaceuticals (NASDAQ:AGIO) Price Target Raised to $34.00 at JPMorgan Chase & Co. - MarketBeat
Fri, 07 Aug 2026 06:56:15 GMTAgios Pharmaceuticals (AGIO) Chief Medical Officer Sarah Gheuens Sells 30,000 Shares - GuruFocus
Thu, 06 Aug 2026 20:14:18 GMTAgios Pharmaceuticals (AGIO) CMO sells 30,000 shares in plan trade - Stock Titan

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Agio.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.